Repeat Biopsy Decision-making
Repeat Biopsy Decision-Making is a clinical decision-making framework that determines the necessity, timing, and methodology of subsequent biopsy procedures in patients with inconclusive or high-risk findings during cervical or urologic cancer screening, distinguishing itself by integrating longitudinal biomarker trends, histopathological reassessment, and risk stratification models to optimize diagnostic accuracy and minimize unnecessary invasive interventions.
91
Publications
6.1K
Citations
549
Authors
208
Institutions
Publications per year
2017–2026
15
91
PCA3 Molecular Urine Assay for Prostate Cancer in Men Undergoing Repeat Biopsy
Leonard S. Marks, Yves Fradet, Ina L. Deras et al. · Urology · 2007 · 442 citations
High-grade prostatic intraepithelial neoplasia
David G. Bostwick, Junqi Qian · Modern Pathology · 2004 · 347 citations · Full text
1–5 of 91
549
3
h-index
3
h-index
3
h-index
3
h-index
Icahn School of Medicine at Mount Sinai, United States
2 publications · 139 citations
2
h-index
1–5 of 549
208

Johns Hopkins University
Baltimore, United States
5 h-index
10 publications
1.4K citations
Memorial Sloan Kettering Cancer Center
New York, United States
4 h-index
18 publications
3.3K citations
The University of Texas Southwestern Medical Center
Dallas, United States
3 h-index
12 publications
408 citations
Erasmus University Rotterdam
Rotterdam, The Netherlands
3 h-index
7 publications
392 citations
University of Michigan
Ann Arbor, United States
3 h-index
19 publications
1.1K citations
Cleveland Clinic
Cleveland, United States
3 h-index
10 publications
896 citations
University of Vienna
Vienna, Austria
3 h-index
18 publications
2K citations

Vanderbilt University
Nashville, United States
3 h-index
6 publications
855 citations
1–8 of 208
15 publications · 1.7K citations
14
h-index
8 publications · 300 citations
8
h-index
6 publications · 750 citations
6
h-index
Repository · 6 publications · 231 citations
6
h-index
5 publications · 1.1K citations
5
h-index
1–5